- Sales increase from EUR 89.9 million to EUR 92.0 million
- EBITDA rises from EUR 10.3 million to EUR 10.4 million
- Forecast confirmed
Trostberg, November 12, 2018 – AlzChem Group AG, a vertically integrated specialty chemicals supplier with leading market positions in selected niche markets, achieved a slight increase in both sales and earnings in the quarter from July to September 2018. Compared to the same period in 2017, consolidated sales improved from EUR 89.9 million to EUR 92.0 million, while earnings before interest, taxes, depreciation and amortization (EBITDA) increased from EUR 10.3 million to EUR 10.4 million despite rising raw material and electricity costs. This results in an EBITDA margin of 11.3% (reference quarter 2017: 11.5%). At EUR 4.4 million, the consolidated net income for the period remained at the previous year's level.
Based on the 9-month period from January to September, the business development of the AlzChem Group was even more positive. At EUR 287.2 million (9M 2017: EUR 272.7 million), the Group achieved organic sales growth of 5.3%. At the same time, EBITDA increased by 8.0% from EUR 38.2 million to EUR 41.3 million, corresponding to an EBITDA margin of 14.4% (9M 2017: 14.0%). The consolidated net income for the period improved by 7.4% from EUR 19.0 million to EUR 20.4 million.
Against the background of the continuing positive business development, the Management Board confirms the forecast for the calendar year 2018. According to this forecast, consolidated sales are expected to rise from EUR 364.5 million to EUR 378.7 million over the 12-month period, while EBITDA is expected to increase from EUR 49.0 million to EUR 54.0 million.
The detailed quarterly statement for the quarter from July to September 2018 can be downloaded from the website www.alzchem.com under Investor Relations/Publications/Financial reports.
About AlzChem Group AG
AlzChem Group AG is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding that are used in a wide variety of different industries. The company has a leading position in select niche markets. The strategic focus of growth and the main focus of its extensive research and development are on the business segment Specialty Chemicals. The company has around 1,500 employees at four sites in Germany and three other sites abroad.